TNF and rheumatoid arthritis: Two types of TNF-α antagonists are used for treating rheumatic diseases, including RA and spondyloarthritides: the soluble TNF-α receptor 2 etanercept and monoclonal antibodies such as infliximab, adalimumab, golimumab, or pegylated-IgG-Fc fragments such as certolizumab.